Ju Liang Selected Research

Thyroid Hormone Receptors (Thyroid Hormone Receptor)

1/2023

Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ju Liang Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 02/2014
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2018
1	Thromboembolism 01/2018
1	Venous Thromboembolism 01/2018
1	Cardiovascular Infections 09/2017
1	Carcinoma (Carcinomatosis) 01/2015
1	Necrosis 06/2007

Drug/Important Bio-Agent (IBA)

3	Peptides (Polypeptides)IBA 01/2022 - 02/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 02/2014
3	MicellesIBA 06/2019 - 02/2014
2	IntegrinsIBA 01/2015 - 02/2014
1	Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA 01/2023
1	AcidsIBA 01/2022
1	DisulfidesIBA 06/2019
1	polycarboxybetaine methacrylateIBA 06/2019
1	caprolactoneIBA 06/2019
1	RivaroxabanIBA 01/2018
1	Heparin (Liquaemin)FDA LinkGeneric 01/2018
1	VenomsIBA 09/2017
1	arginyl-glycyl-aspartic acidIBA 01/2015
1	CurcuminIBA 01/2015
1	Drug CarriersIBA 02/2014
1	Propidium (Propidium Iodide)IBA 06/2007
1	Annexin A5IBA 06/2007
1	Acridine OrangeIBA 06/2007
1	BromidesIBA 06/2007

Therapy/Procedure

1	Lasers (Laser) 01/2015